ACQUISITION IN THE PHARMA WORLD NOW A TREND?
The pharmaceutical companies have been acquiring new assets and subsidiaries in order to take over their research and intellectual property this has become a growing trend in the pharmaceutical world. Here’s a look at some new acquisitions in pharma. Alkem Laboratories Limited informed the markets on Friday that the company has acquired an new undertaking, as a whole and on a going and running concern basis from Cachet Pharmaceuticals Private Limited, who is a subsidiary of the company. The cost of acquisition is a whopping Rs. 51,85,00,000. In the press release that informed more about the acquisition,The company has agreed that it was using a different permit to manufacture some of its liquid products and was having other products made by a different manufacturer as it lacked the license for those products. Hence, it was proposed to acquire the required undertaking with a view to manufacture most of its requirements of the products that it is aiming to manufacture that were before bought in by the outside manufacturer. This will have an impact on the market as the products made by the company will now be charged differently as the means of manufacture are changed.